Lanzamiento Enero 2027

Ensayo controlado aleatorizado2020

Does Creatine Supplementation Affect Renal Function in Patients with Peripheral Artery Disease? A Randomized, Double Blind, Placebo-controlled, Clinical Trial

Domingues WJR, Ritti-Dias RM, Cucato GG, Wolosker N, Zerati AE, Puech-Leão P, Nunhes PM, Moliterno AA, Avelar A

Annals of vascular surgery · 7 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Organización sin fines de lucro
Fundacion Araucaria
Organización sin fines de lucro
Fundação Araucária
Gobierno
Fundação de Amparo à Pesquisa do Estado do Amazonas
Subvenciones
Fundacion Araucaria (002/2017); Fundação Araucária (#002/2017); Fundação de Amparo à Pesquisa do Estado do Amazonas (#062.03159.2014)

Según 3 financiadores declarados.

Publicación

Publicado
2019-09-26 · Ann Vasc Surg · vol. 63 · págs. 45–52
Editorial
Elsevier BV
Citado
12 citas · más que el 57% de estudios similares · 0.4× el promedio de su campo
Referencias
42 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Muscle metabolism and nutrition · Peripheral Artery Disease Management · Dialysis and Renal Disease Management
Palabras clave
creatine monohydrate, creatine supplementation, peripheral arterial disease, renal function, creatinine clearance, serum creatinine, renal safety, dietary supplements, cardiovascular risk factors, diabetes mellitus, dyslipidemia, smoking, physical inactivity
MeSH
kidney, humans, creatine, creatinine, glomerular filtration rate, treatment outcome, double-blind method, time factors, dietary supplements, adult, aged, aged, 80 and over, middle aged, brazil, female, male, peripheral arterial disease, renal elimination

9 autores

  • Wagner Jorge Ribeiro Domingues🇧🇷 · autor de correspondenciaUniversidade Federal do Amazonas
  • Raphael Mendes Ritti‐Dias🇧🇷Universidade Nove de Julho
  • Gabriel Grizzo Cucato🇧🇷Hospital Israelita Albert Einstein
  • Nelson Wolosker🇧🇷Hospital Israelita Albert Einstein
  • Antônio Eduardo Zerati
  • Pedro Puech‐Leão🇧🇷Universidade de São Paulo
  • Pollyana Mayara Nunhes🇧🇷Universidade Estadual de Maringá
  • André Alberto Moliterno🇧🇷Universidade Estadual de Maringá
  • Ademar Avelar🇧🇷Universidade Estadual de Maringá

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Case studies and reviews have shown that creatine supplementation can affect kidney function. The objective of this study is to verify the effects of 8 weeks of creatine supplementation on renal function (creatinine clearance: primary outcome) in patients with symptomatic peripheral arterial disease.

Methods

Twenty-nine patients, of both genders, were randomized (1:1) in a double-blind manner for administration of Placebo (PLA; n = 15) or creatine monohydrate (Cr; n = 14). The supplementation protocol consisted of 20 g/day for 1 week divided into 4 equal doses (loading phase), followed by single daily doses of 5 g in the subsequent 7 weeks (maintenance phase). Before and after the supplementation period, markers of renal function, serum creatinine, creatinine excretion rate, and creatinine clearance were evaluated. The Generalized Estimation Equation Model was used for comparison between groups. The level of significance was P < 0.05.

Results

No significant differences were found between groups before and after the intervention for serum creatinine (Cr: pre 1.00 ± 0.15 mL/dL vs. post 1.07 ± 0.16 mL/dL; PLA: pre 1.30 ± 0.53 mL/dL vs. post 1.36 ± 0.47 mL/dL, P = 0.590), creatinine excretion rate (Cr: pre 81.73 ± 43.80 mg/dL vs. post 102.92 ± 59.57 mg/dL; PLA: pre 74.37 ± 38.90 mg/dL vs. post 86.22 ± 39.94 mg/dL, P = 0.560), or creatinine clearance (Cr; pre 108 ± 59 mL/min/1.73 m2 vs. post 117 ± 52 mL/min/1.73 m2; PLA: pre 88 ± 49 mL/min/1.73 m2 vs. post 82 ± 47 mL/min/1.73 m2, P = 0.366).

Conclusions

Eight weeks of creatine supplementation is safe and does not compromise the renal function of patients with peripheral arterial disease.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.